Skip to main content
. 2020 May 30;12(6):1414. doi: 10.3390/cancers12061414

Figure 1.

Figure 1

Detection of circulating tumor DNA (ctDNA) in baseline samples. (A) Overview of the patient cohort and the ctDNA mutations detected. The upper panel shows patient characteristics, while the lower panels show tissue and baseline ctDNA mutations detected. (B) Correlation between the baseline ctDNA level and number of metastatic sites (n = 12) analyzed with Spearman’s correlation coefficient (r).